Authors: WAGNER D WAGENBRETH I STACHANKUNSTYR R THOMA HA HEMMERLING AE FLIK J

Citation: D. Wagner et al., HEPATITIS-B VACCINATION OF IMMUNOSUPPRESSED HEART-TRANSPLANT RECIPIENTS WITH THE VACCINE HEPA-GENE-3 CONTAINING PRE-S1-GENE, PRE-S2-GENE, AND S-GENE-PRODUCTS, The Clinical investigator, 72(5), 1994, pp. 350-352

Authors: DRESCHER J WAGNER D HAVERICH A FLIK J STACHANKUNSTYR R VERHAGEN W WAGENBRETH I

Citation: J. Drescher et al., NOSOCOMIAL HEPATITIS-B VIRUS-INFECTIONS IN CARDIAC TRANSPLANT RECIPIENTS TRANSMITTED DURING TRANSVENOUS ENDOMYOCARDIAL BIOPSY, The Journal of hospital infection, 26(2), 1994, pp. 81-92

Authors: WAHLERS T KOTZERKE B WAGENBRETH I HAUSEN B HAVERICH A

Citation: T. Wahlers et al., PREVENTIVE TREATMENT OF RENAL IMPAIRMENT AND GRAFT-REJECTION IN CARDIAC TRANSPLANTATION USING CYCLOSPORINE WITH AN ORAL PROSTAGLANDIN ANALOG, Transplantation proceedings, 26(5), 1994, pp. 2743-2744

Authors: HAUSEN B DEMERTZIS S SCHAFERS HJ WAHLERS TH WAGENBRETH I HAVERICH A

Citation: B. Hausen et al., THE IMPACT OF EARLY POSTOPERATIVE CYCLOSPORINE SERUM LEVELS ON THE INCIDENCE OF CARDIAC ALLOGRAFT-REJECTION, European journal of cardio-thoracic surgery, 7(5), 1993, pp. 257-261

Authors: DEMERTZIS S WIPPERMANN J SCHAPER J WAHLERS T SCHAFERS HJ WAGENBRETH I HAUSEN B HAVERICH A

Citation: S. Demertzis et al., UNIVERSITY-OF-WISCONSIN VERSUS ST-THOMAS-HOSPITAL SOLUTION FOR HUMAN DONOR HEART PRESERVATION, The Annals of thoracic surgery, 55(5), 1993, pp. 1131-1137